SNAP25 and Creutzfeldt Jacob disease: Our current and previous results suggest that in CJD, both generic neuroaxonal (t-tau) and some synaptic (at least, α-synuclein and SNAP-25) biomarkers reflect the extent of neuronal (i.e., grey matter) degeneration and the speed at which it develops.